Baxter

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Baxter 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BAX

Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. It operates through the following segments: Americas, Europe, Middle East and Africa (EMEA), Asia-Pacific (APAC), and Hillrom. 

CEO
Andrew P. Hider
CEOAndrew P. Hider
Employees
38,000
Employees38,000
Headquarters
Deerfield, Illinois
HeadquartersDeerfield, Illinois
Founded
1931
Founded1931
Employees
38,000
Employees38,000

BAX Key Statistics

Market cap
9.22B
Market cap9.22B
Price-Earnings ratio
-34.81
Price-Earnings ratio-34.81
Dividend yield
3.75%
Dividend yield3.75%
Average volume
9.63M
Average volume9.63M
High today
$18.17
High today$18.17
Low today
$17.87
Low today$17.87
Open price
$18.15
Open price$18.15
Volume
218.85K
Volume218.85K
52 Week high
$37.74
52 Week high$37.74
52 Week low
$17.40
52 Week low$17.40

Stock Snapshot

As of today, Baxter(BAX) shares are valued at $17.95. The company's market cap stands at 9.22B, with a P/E ratio of -34.81 and a dividend yield of 3.7%.

On 2025-11-19, Baxter(BAX) stock moved within a range of $17.87 to $18.17. With shares now at $17.95, the stock is trading +0.4% above its intraday low and -1.2% below the session's peak.

Trading volume for Baxter(BAX) stock has reached 218.85K, versus its average volume of 9.63M.

The stock's 52-week range extends from a low of $17.40 to a high of $37.74.

The stock's 52-week range extends from a low of $17.40 to a high of $37.74.

BAX News

TipRanks 9h
Baxter Hit with Class Action Lawsuit over Defective Novum LVP Infusion Pumps

A class action lawsuit was filed against Baxter International (BAX) on October 16, 2025. The plaintiffs (shareholders) alleged that they bought BAX stock at art...

Simply Wall St 7d
How Legal and Regulatory Setbacks Around Novum Devices Will Impact Baxter International Investors

Baxter International recently faced multiple class action lawsuits alleging the company misled investors about severe safety defects in its Novum LVP and Novum...

How Legal and Regulatory Setbacks Around Novum Devices Will Impact Baxter International Investors

Analyst ratings

70%

of 20 ratings
Buy
20%
Hold
70%
Sell
10%

People also own

Based on the portfolios of people who own BAX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.